The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Touchstone invests £1.4m in Featurespace round

4 Oct 2017 07:00

RNS Number : 6116S
Touchstone Innovations PLC
04 October 2017
 

 

4 October 2017

 

Touchstone Innovations plc

 

Touchstone invests £1.4m in £16.5m funding round in Featurespace, the machine learning fraud prevention company

 

Touchstone Innovations plc (AIM: IVO, 'the Group', 'Touchstone') has participated in a £16.5m funding round in Featurespace Limited ("Featurespace" or "the Company"), a leading machine-learning, fraud prevention company.

 

Touchstone has committed £1.4 million to the round, which was led by Highland Europe. The round was also supported by Worldpay Group plc, a leading global payment processing company, and Invoke Capital, a technology investment company. The new funding will enable Featurespace to drive revenues of its product platform and to continue to expand internationally.

 

Following this new investment, Touchstone will hold a 27.9% interest in the Company. The current valuation, including this investment is £15.6 million.

 

Featurespace, based in Cambridge, is an Adaptive Behavioural Analytics company that is addressing the fast-growing fraud detection and prevention market. According to MarketsandMarkets, this market was worth $14.8bn in 2014 and is growing at 18% per annum.

 

The Company has developed a machine learning software platform, ARIC, that identifies abnormal behaviour in high-volume, real-time customer interactions. Through analysing every individual customer interaction and understanding normal behaviour, Featurespace helps to protect customers from fraud attack, and reduces the costs of lost transactions.

 

Featurespace has developed an ambitious growth plan, which focuses on expanding further within the UK and the USA. The business recently opened offices in North Carolina and New York, and last year signed a deal with TSYS, one of the largest payments processors in the US, in which Featurespace's adaptive behavioural analytics platform is being used to reduce fraud for TSYS' clients. The injection of new capital from this funding round will enable the Company to pursue further sales through this channel as well as direct sales to new customers in both existing and new markets.

 

Martina King, CEO of Featurespace, said:

"We are working with our clients to protect businesses and consumers in the fight against fraud. This funding round will enable us to continue to grow our business internationally, building on our progress as a leader in machine learning fraud prevention."

Jon Edington, Director of Technology Ventures at Touchstone Innovations, added:

 

"Featurespace is a business with world-class machine-learning technology married to a management team with an excellent track record, and has the potential to be a substantial international entity.

 

"The evolution and development of Featurespace is a classic example of our approach.

 

"We initially worked with the late Professor Bill Fitzgerald who was head of signal processing and applied statistics at the University of Cambridge and Dave Excell, his PhD student, to develop the technology and concept and made our initial investment into the Company in 2012.

"Subsequently, we have continued to support the business with further funding as well as helping to recruit the management team with the right expertise and experience.

 

"More recently we have sought to build a strong syndicate around the business, widening the pool of investors and bringing in industry expertise.

 

"Today's news reflects the growing maturity of the business and its potential for growth."

 

-Ends-

 

For further information contact:

 

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

 

Jon Davies, Director of Communications

 

 

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

 

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

 

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

About Touchstone Innovations - www.touchstoneinnovations.com

 

Touchstone Innovations plc ("Touchstone" formerly Imperial Innovations Group plc) creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the Golden Triangle, the region broadly bounded by London, Cambridge and Oxford.

 

This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

 

Touchstone supports scientists and entrepreneurs in the commercialisation of their ideas through protecting and licensing out intellectual property (through its Technology Transfer subsidiary, Imperial Innovations Limited), by leading the formation of new companies, by recruiting high-calibre management teams and by providing investment and encouraging co-investment. Touchstone remains an active investor over the life of its portfolio companies, with the majority of Touchstone's investment going into businesses in which it is already a shareholder.

 

Since becoming a public company in 2006, Touchstone has raised more than £440.0 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has a £74.4 million term debt facility from the European Investment Bank (EIB).

 

Between Touchstone's admission to AIM (August 2006) and 31 July 2017, Touchstone has invested a total of £372.4 million across its portfolio companies, currently valued at £461.1 million and in addition has generated £51.0 million of cash realisations. In aggregate, Touchstone's portfolio, excluding Apollo Therapeutics and UCL Technology Fund, has collectively raised investment of more than £1.7 billion.

 

 

About Featurespace - www.featurespace.co.uk

 

Featurespace™ is the world-leader in Adaptive Behavioral Analytics and creator of the ARIC™ platform, a real-time machine learning software system developed out of the University of Cambridge.

 

The ARIC™ platform - a real-time, machine learning software system - monitors individual behaviors to catch new fraud attacks as they happen. At the same time, the increased accuracy of understanding customer behavior reduces the number of genuine customers whose purchases and transactions are incorrectly declined.

 

Featurespace is based in Cambridge, UK, and the Company has deployed ARIC™ to organizations that have services or products deployed in over 180 countries.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSUFMDFWSEFS
Date   Source Headline
7th Jun 20177:00 amRNSForm 8 (OPD) IP Group PLC
6th Jun 201711:19 amRNSForm 8.3 - Touchstone Innovations
5th Jun 201712:46 pmRNSForm 8.3 - Touchstone Innovations Plc
1st Jun 20172:41 pmBUSForm 8.3 - Touchstone Innovations plc
1st Jun 20177:00 amRNSChairman's letter to shareholders
31st May 20175:58 pmRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
31st May 201712:01 pmRNSForm 8.3 - Touchstone Innovations Plc
30th May 20177:00 amRNSForm 8.3 - Touchstone Innovations Plc
26th May 201712:29 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:15 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:14 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:10 pmRNSForm 8.3 - IP Group Plc
24th May 20172:55 pmRNSForm 8.3 - IP Group plc
24th May 20172:52 pmRNSForm 8.3 - Touchstone Innovations plc
24th May 20172:51 pmRNSForm 8.3 - IP Group Plc
24th May 20172:41 pmRNSForm 8.3 - Touchstone Innovations Plc
24th May 20171:15 pmRNSForm 8.3 - Touchstone Innovations Plc
24th May 201711:17 amBUSForm 8 (DD) - Touchstone Innovations Plc.
23rd May 201712:05 pmRNSUpdate on possible offer
23rd May 201711:45 amRNSForm 8.3 - Touchstone Innovations Plc
23rd May 201710:33 amRNSStatement re Possible Offer
23rd May 20177:01 amRNSStatement re Possible Offer
21st Apr 201711:21 amRNSInnovations invests £2.9m in Abzena placing
6th Apr 20177:00 amRNSInnovations provides seed funding for Cardian
31st Mar 20177:00 amRNSHalf Yearly Report
20th Mar 20177:05 amRNSInnovations supports funding round in Pulmocide
16th Mar 20177:00 amRNSInnovations invests in Cell Medica funding round
14th Mar 20177:00 amRNSInnovations supports funding round in Resolver
6th Mar 20177:00 amRNSInnovations leads £12m funding round in Garrison
28th Feb 201711:11 amRNSNotice of Results
21st Feb 20177:03 amRNSCell Medica granted FDA Fast Track designation
26th Jan 20172:00 pmRNSDirectorate Change
5th Jan 20177:00 amRNSChange of name to Touchstone Innovations plc
4th Jan 20179:00 amRNSAppointment of Joint Broker
20th Dec 201612:03 pmRNSPsiOxus signs exclusive licence agreement with BMS
28th Nov 20167:02 amRNSPortfolio company TopiVert receives IND approval
23rd Nov 20165:56 pmRNSGrant of share options
21st Nov 201612:53 pmRNSResult of AGM
28th Oct 201612:30 pmRNSProposed change of name to Touchstone Innovations
28th Oct 201612:29 pmRNSPosting of Annual Report and Notice of AGM
24th Oct 20167:12 amRNSVeryan announces completion of subject enrolment
13th Oct 20167:00 amRNSFinal Results
10th Oct 20161:02 pmRNSCrescendo Biologics sign collaboration with Takeda
6th Oct 20167:02 amRNSFirst patients dosed in TopiVert's Phase IIa study
3rd Oct 201612:10 pmRNSSale of Innovations portfolio company Permasense
21st Sep 20167:06 amRNSInnovations invests £5.1m in Artios Pharma Limited
14th Sep 201612:02 pmRNSNotice of Results
13th Sep 20164:08 pmRNSTR-1: Notification of major interest in shares
9th Sep 20161:15 pmRNSHolding(s) in Company
6th Sep 20164:17 pmRNSEdison issues update on Imperial Innovations (IVO)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.